United States Phosphodiesterase Inhibitor Market Report 2017

February 2017 | 95 pages | ID: UDBFAA18C61EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Phosphodiesterase Inhibitor

Revenue, means the sales value of Phosphodiesterase Inhibitor

This report studies sales (consumption) of Phosphodiesterase Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actelion Pharmaceuticals
• United Therapeutics Corporation
• Gilead sciences
• Bayer AG
• SteadyMed
• GlaxoSmithKline
• Pfizer
• Reata Pharmaceuticals
• Arena Pharmaceuticals
• Merck

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Phosphodiesterase Inhibitor in each application, can be divided into

• Application 1
• Application 2

Contents

United States Phosphodiesterase Inhibitor Market Report 2017

1 PHOSPHODIESTERASE INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Classification of Phosphodiesterase Inhibitor
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Phosphodiesterase Inhibitor
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Phosphodiesterase Inhibitor (2012-2022)
  1.4.1 United States Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2022)
  1.4.2 United States Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)

2 UNITED STATES PHOSPHODIESTERASE INHIBITOR COMPETITION BY MANUFACTURERS

2.1 United States Phosphodiesterase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Phosphodiesterase Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Phosphodiesterase Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Phosphodiesterase Inhibitor Market Competitive Situation and Trends
  2.4.1 Phosphodiesterase Inhibitor Market Concentration Rate
  2.4.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PHOSPHODIESTERASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Phosphodiesterase Inhibitor Sales and Market Share by States (2012-2017)
3.2 United States Phosphodiesterase Inhibitor Revenue and Market Share by States (2012-2017)
3.3 United States Phosphodiesterase Inhibitor Price by States (2012-2017)

4 UNITED STATES PHOSPHODIESTERASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Phosphodiesterase Inhibitor Sales and Market Share by Type (2012-2017)
4.2 United States Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
4.3 United States Phosphodiesterase Inhibitor Price by Type (2012-2017)
4.4 United States Phosphodiesterase Inhibitor Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PHOSPHODIESTERASE INHIBITOR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Phosphodiesterase Inhibitor Sales and Market Share by Application (2012-2017)
5.2 United States Phosphodiesterase Inhibitor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PHOSPHODIESTERASE INHIBITOR MANUFACTURERS PROFILES/ANALYSIS

6.1 Actelion Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Actelion Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 United Therapeutics Corporation
  6.2.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Gilead sciences
  6.3.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer AG
  6.4.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 SteadyMed
  6.5.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 SteadyMed Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Reata Pharmaceuticals
  6.8.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Reata Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Arena Pharmaceuticals
  6.9.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Arena Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 PHOSPHODIESTERASE INHIBITOR MANUFACTURING COST ANALYSIS

7.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PHOSPHODIESTERASE INHIBITOR MARKET FORECAST (2017-2022)

11.1 United States Phosphodiesterase Inhibitor Sales, Revenue Forecast (2017-2022)
11.2 United States Phosphodiesterase Inhibitor Sales Forecast by Type (2017-2022)
11.3 United States Phosphodiesterase Inhibitor Sales Forecast by Application (2017-2022)
11.4 Phosphodiesterase Inhibitor Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Phosphodiesterase Inhibitor
Table Classification of Phosphodiesterase Inhibitor
Figure United States Sales Market Share of Phosphodiesterase Inhibitor by Type in 2015
Table Application of Phosphodiesterase Inhibitor
Figure United States Sales Market Share of Phosphodiesterase Inhibitor by Application in 2015
Figure United States Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2022)
Figure United States Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Table United States Phosphodiesterase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table United States Phosphodiesterase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Table United States Phosphodiesterase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table United States Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 United States Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table United States Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2015
Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers
Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers
Table United States Phosphodiesterase Inhibitor Sales by States (2012-2017)
Table United States Phosphodiesterase Inhibitor Sales Share by States (2012-2017)
Figure United States Phosphodiesterase Inhibitor Sales Market Share by States in 2015
Table United States Phosphodiesterase Inhibitor Revenue and Market Share by States (2012-2017)
Table United States Phosphodiesterase Inhibitor Revenue Share by States (2012-2017)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by States (2012-2017)
Table United States Phosphodiesterase Inhibitor Price by States (2012-2017)
Table United States Phosphodiesterase Inhibitor Sales by Type (2012-2017)
Table United States Phosphodiesterase Inhibitor Sales Share by Type (2012-2017)
Figure United States Phosphodiesterase Inhibitor Sales Market Share by Type in 2015
Table United States Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
Table United States Phosphodiesterase Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Table United States Phosphodiesterase Inhibitor Price by Type (2012-2017)
Figure United States Phosphodiesterase Inhibitor Sales Growth Rate by Type (2012-2017)
Table United States Phosphodiesterase Inhibitor Sales by Application (2012-2017)
Table United States Phosphodiesterase Inhibitor Sales Market Share by Application (2012-2017)
Figure United States Phosphodiesterase Inhibitor Sales Market Share by Application in 2015
Table United States Phosphodiesterase Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States Phosphodiesterase Inhibitor Sales Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Gilead sciences Basic Information List
Table Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table SteadyMed Basic Information List
Table SteadyMed Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure United States Phosphodiesterase Inhibitor Production and Growth Rate Forecast (2017-2022)
Figure United States Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table United States Phosphodiesterase Inhibitor Production Forecast by Type (2017-2022)
Table United States Phosphodiesterase Inhibitor Consumption Forecast by Application (2017-2022)
Table United States Phosphodiesterase Inhibitor Sales Forecast by States (2017-2022)
Table United States Phosphodiesterase Inhibitor Sales Share Forecast by States (2017-2022)